Mariana Costa

sciencewithmari.bsky.social

06 July 2026 16:04

As someone living with endometriosis, this session resonated with me. Research reminds us that treatment isn’t only about controlling symptoms, it’s also about side effects, information and being heard. @theeshre5.bsky.social @eshre.bsky.social

Dr. Pedro Avanci Fontenele

drpedrofontenele.bsky.social

30 June 2026 20:58

🇧🇷Na reprodução humana, o desafio pode não ser o GLP-1, mas o que acontece após sua suspensão. 🇬🇧In reproductive medicine, the challenge may not be GLP-1 itself, but what happens after discontinuation. We'll discuss this at ESHRE London 2026. @eshre.bsky.social @theeshre5.bsky.social

hmelzeiny.bsky.social

30 May 2026 09:35

Average age of women who used NC is 41.80+or-3.56. I believe majority in practice will do NC at that age , however the target population here should be women between 45-50 with regular cycle . Has the study accounted for this age bracket? #ESHREjc

carolineroelens.bsky.social

30 May 2026 09:33

NC is the preferred approach regardless of age. With the possibility of incorporating some flexibility, such as using NPP, triggering at smaller follicle sizes, or adopting flexible FET scheduling (6 or 7 days after hCG trigger), we have all the tools needed to make it feasible. #ESHREjc

Claudia Massarotti

cmassarottimd.bsky.social

29 May 2026 21:36

I second everything. The data are relevant and should be considered when choosing/counseling. But let's not demonize artificial cycles which are frequently a safe and effective option for many women (and sometimes the only alternative to drop out) #ESHREjc